CooperSurgical predicts $100 million turnover within two years
This article was originally published in Clinica
Executive Summary
The Cooper Companies' women's health business, CooperSurgical, had sales of $13 million in the quarter and $26 million over six months. The division had operating income of $2.3 million and $4.1 million for the same periods. The Lake Forest, California company says annual revenue is approaching $60 million and this could increase to $100 million within two years. Its operating margins are expected to approach 20% by the end of the fiscal year. The company has recently added a range of new products through acquisition or marketing alliances. These include products in the MedaSonics foetal monitor line, which are manufactured by Analogic under an OEM arrangement; a range of bone measurement systems for the evaluation of osteoporosis - CooperSurgical markets these under an agreement with Norland Medical Systems; and the LuMax pro fibre optic cystometry system, used to diagnose the cause of female incontinence. It bought LuMax from Medamicus in April.